Saturday, 18 September 2021 05:20

CDC-led study ranks the 3 vaccines approved for use in US for effectiveness

Rate this item
(0 votes)

A head-to-head study of all three authorized coronavirus vaccines in the United States finds the Moderna vaccine is slightly more effective than Pfizer's in real-life use in keeping people out of the hospital, and Johnson & Johnson's Janssen vaccine comes in third, but still providing 71% protection.

Pfizer's vaccine provided 88% protection against hospitalization, and Moderna's was 93% effective.

The US Centers for Disease Control and Prevention led a nationwide study of vaccination involving more than 3,600 adults hospitalized for Covid-19 between March and August.

"Among U.S. adults without immunocompromising conditions, vaccine effectiveness against Covid-19 hospitalization during March 11--August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)," the team wrote in the CDC's weekly report on death and disease, the MMWR.

"Although these real-world data suggest some variation in levels of protection by vaccine, all FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

They found that the biggest difference between the vaccine made by Moderna and Pfizer/BioNtech's vaccine was driven by a decline that started about four months after people were fully vaccinated with Pfizer's vaccine.

"Differences in vaccine effectiveness between the Moderna and Pfizer-BioNTech vaccine might be due to higher mRNA content in the Moderna vaccine, differences in timing between doses (3 weeks for Pfizer-BioNTech versus 4 weeks for Moderna), or possible differences between groups that received each vaccine that were not accounted for in the analysis," the team wrote.

"A single dose of the Janssen viral vector vaccine had comparatively lower anti-SARS-CoV-2 antibody response and vaccine effectiveness against Covid-19 hospitalizations," they added.

"Understanding differences in vaccine effectiveness by vaccine product can guide individual choices and policy recommendations regarding vaccine boosters. All FDA-approved or authorized Covid-19 vaccines provide substantial protection against Covid-19 hospitalization."

CDC worked with researchers across the country to study 3,689 patients at 21 hospitals in 18 states for the study. They also looked at antibodies in the blood of 100 healthy volunteers after they'd been vaccinated with one of the three available vaccines.

 

CNN

April 19, 2025

Nigerian Stock market rebounds as capitalization rises by N240bn

The Nigerian Exchange Limited (NGX) bounced back on Thursday as market capitalization increased by N240…
April 17, 2025

Afenifere accuses Tinubu of ‘destructuring’ Nigeria, demands urgent reforms

Pan-Yoruba socio-political group, Afenifere, has criticized President Bola Tinubu’s administration, accusing it of dismantling the…
April 16, 2025

A strategy to get more done—and feel less stressed

For some people, the expression “You have as many hours in the day as Beyoncé”…
April 19, 2025

UFO: US Navy reports on mysterious aircraft launching from sea

A group of unidentified flying objects spotted by Navy sailors is raising eyebrows after witnesses…
April 19, 2025

Gunmen kill 17 in fresh attacks on Benue communities

Suspected armed militia launched deadly attacks on communities in Logo and Ukum Local Government Areas…
April 19, 2025

Here’s the latest as Israel-Hamas war enters Day 561

Israeli strikes hit dozens of targets in Gaza as ceasefire efforts stall Israeli airstrikes hit…
April 15, 2025

Is it finally safe to ditch your phone case? I put it to the test

Thomas Germain With smartphones tougher than ever, a new wave of phone minimalists say cases…
January 08, 2025

NFF appoints new Super Eagles head coach

The Nigeria Football Federation (NFF) has appointed Éric Sékou Chelle as the new Head Coach…

NEWSSCROLL TEAM: 'Sina Kawonise: Publisher/Editor-in-Chief; Afolabi Ajibola: IT Manager;
Contact Us: [email protected] Tel/WhatsApp: +234 811 395 4049

Copyright © 2015 - 2025 NewsScroll. All rights reserved.